Bieche I - Search Results

1

Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial.

Tubiana-Hulin M, Becette V, Bieche I, Mauriac L, Romieu G, Bibeau F, Macgrogan G, Bourgeois H, Chollet P, Defrance R, Spyratos F. Tubiana-Hulin M, et al. Among authors: bieche i. Anticancer Res. 2007 Jul-Aug;27(4C):2689-96. Anticancer Res. 2007. PMID: 17695434 Free article. Clinical Trial.

2

Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.

Spyratos F, Bouchet C, Tozlu S, Labroquere M, Vignaud S, Becette V, Lidereau R, Bieche I. Spyratos F, et al. Among authors: bieche i. Anticancer Res. 2002 Sep-Oct;22(5):2997-3003. Anticancer Res. 2002. PMID: 12530032

3

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. Among authors: bieche i. Clin Cancer Res. 2003 Apr;9(4):1259-66. Clin Cancer Res. 2003. PMID: 12684393

4

Prognostic value of ERBB family mRNA expression in breast carcinomas.

Bièche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R. Bièche I, et al. Int J Cancer. 2003 Sep 20;106(5):758-65. doi: 10.1002/ijc.11273. Int J Cancer. 2003. PMID: 12866037

5

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Girault I, Tozlu S, Lidereau R, Bièche I. Girault I, et al. Among authors: bieche i. Clin Cancer Res. 2003 Oct 1;9(12):4415-22. Clin Cancer Res. 2003. PMID: 14555514

6

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.

Bièche I, Girault I, Urbain E, Tozlu S, Lidereau R. Bièche I, et al. Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26. Breast Cancer Res. 2004. PMID: 15084249 Free PMC article.

7

Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.

Girault I, Andrieu C, Tozlu S, Spyratos F, Bièche I, Lidereau R. Girault I, et al. Among authors: bieche i. Cancer Lett. 2004 Nov 8;215(1):101-12. doi: 10.1016/j.canlet.2004.05.006. Cancer Lett. 2004. PMID: 15374639

8

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

Bièche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Bièche I, et al. Clin Cancer Res. 2004 Oct 15;10(20):6789-95. doi: 10.1158/1078-0432.CCR-04-0306. Clin Cancer Res. 2004. PMID: 15501955

9

Identification of a three-gene expression signature of poor-prognosis breast carcinoma.

Bièche I, Tozlu S, Girault I, Lidereau R. Bièche I, et al. Mol Cancer. 2004 Dec 20;3(1):37. doi: 10.1186/1476-4598-3-37. Mol Cancer. 2004. PMID: 15606925 Free PMC article.

10

Update on inflammatory breast cancer.

Lerebours F, Bieche I, Lidereau R. Lerebours F, et al. Among authors: bieche i. Breast Cancer Res. 2005;7(2):52-8. doi: 10.1186/bcr997. Epub 2005 Jan 20. Breast Cancer Res. 2005. PMID: 15743511 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters